Chemoinformaics analysis of (6S)-2-METHYL-6-(4-METHYLPHENYL)HEPT-2-EN-4-ONE
Molecular Weight | 216.324 | nRot | 4 |
Heavy Atom Molecular Weight | 196.164 | nRig | 20 |
Exact Molecular Weight | 216.151 | nRing | 1 |
Solubility: LogS | -1.395 | nHRing | 0 |
Solubility: LogP | 0.481 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
nHA | 1 | APOL | 39.1879 |
nHD | 0 | BPOL | 20.9321 |
QED | 0.641 |
Synth | 3.912 |
Natural Product Likeliness | 1.976 |
NR-PPAR-gamma | 0.013 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.003 |
Pgp-sub | 0.999 |
HIA | 0.6 |
CACO-2 | -5.672 |
MDCK | 0.0000165 |
BBB | 0.136 |
PPB | 0.483127 |
VDSS | 1.907 |
FU | 0.277674 |
CYP1A2-inh | 0.033 |
CYP1A2-sub | 0.974 |
CYP2c19-inh | 0.023 |
CYP2c19-sub | 0.889 |
CYP2c9-inh | 0.006 |
CYP2c9-sub | 0.789 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.847 |
CYP3a4-inh | 0.033 |
CYP3a4-sub | 0.923 |
CL | 8.576 |
T12 | 0.892 |
hERG | 0.017 |
Ames | 0.068 |
ROA | 0.367 |
SkinSen | 0.041 |
Carcinogencity | 0.014 |
EI | 0.016 |
Respiratory | 0.18 |
NR-Aromatase | 0.051 |
Antiviral | Yes |
Prediction | 0.760358 |